In 2024, Shenzhen Yanmade Technology Inc. achieved a net profit growth of over 40%, with an increase in both shipment volume and revenue from new businesses such as Semiconductors testing equipment.
Shenzhen Yanmade Technology Inc.'s revenue and net income for the year 2024 are 0.498 billion yuan and 0.096 billion yuan respectively, which represent year-on-year growth of 52.20% and 40.46%; the company's new businesses, including semiconductor testing equipment and automotive electronics, also contributed a certain share during this reporting period, with both shipment volumes and revenue growing simultaneously.
Humanoid robots have already entered factories to work as a structured team, and this field may become one of the first practical applications for Siasun Robot&Automation.
According to media reports, the Walker S1 industrial humanoid robot from Shenzhen UBTECH Technology Co., Ltd. in Guangdong has now officially started working at the ZEEKR 5G smart factory of Geely Autos located in Ningbo's Qianwan New Area, Zhejiang. CITIC SEC's Research Reports indicate that since 2023, there has been an explosive growth in new humanoid robot products both domestically and internationally, and it is expected that industrial manufacturing will become the first scenario for humanoid robots to be implemented.
Limit up during the day and a warning at night? JiangSu WuZhong Pharmaceutical Development's annual report may receive an audit report with an inability to express an opinion | Quick read of the announcement.
① Due to various reasons such as overdue accounts receivable and receivables overdue in the trade business, JiangSu WuZhong Pharmaceutical Development does not rule out the possibility of receiving an audit report expressing an inability to issue an opinion in the 2024 report. ② In addition to being investigated for violations of information disclosure and multiple Bearish factors, JiangSu WuZhong is currently in a precarious situation.
Jointown Pharmaceutical Group invested 0.673 billion to participate in the restructuring, planning to "take control" of Special Treat Meigu and increase investment in medical aesthetics?| Quick read of the announcement.
① Jointown Pharmaceutical Group plans to invest 0.673 billion yuan to participate in the restructuring of Aoyuan Meigu; ② In recent years, Jointown Pharmaceutical Group's medical aesthetics business has grown rapidly and has established partnerships with many domestic medical aesthetics giants, clearly indicating an intention to strengthen this sector.
The major shareholder's pledge ratio is nearly 100%, a significant downward revision of performance is anticipated, and the gaming giant Special Treat Huadong has multiple "troubles" | Quick read the announcement.
① On April 23, the stock price of Special Treat Hu Tong hit the daily limit down. By the close, the company's stock price was 6.70 yuan, down 3.87%; ② After this stock pledge, Wang Ji has pledged a total of 0.755 billion shares, accounting for 98.77% of his holdings in the company; ③ Special Treat Hu Tong has stated that striving to "Take off the Hat" is one of the important goals for the company by 2025, but the performance forecast for 2024 has been significantly revised down.
There are no plans for mergers and acquisitions in the humanoid Robot Concept business! Robot Concept stocks urgently release unusual movement announcements | Compilation of after-market announcements.
Yingli Co., Ltd.: Plans to purchase 77.9385% stake in YouteLi. Stocks will be resumed trading.